Exploring the genetics of minimally verbal children with autism
Genetic Investigation of Minimally Verbal Children with ASD
['FUNDING_OTHER'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-10689725
This study is looking at the genes of children with Autism Spectrum Disorder who don’t speak much to find out what might make them different, which could help us understand their needs better and improve how we support them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10689725 on ClinicalTrials.gov |
What this research studies
This research investigates the genetic factors associated with Autism Spectrum Disorder (ASD) in children who are minimally verbal. By deeply analyzing the genetic profiles of these children, the study aims to identify specific genetic risk factors that may contribute to their unique behavioral and cognitive characteristics. The research will involve collecting and studying genetic data from a cohort of minimally verbal children, enhancing our understanding of the genetic diversity within ASD. This could lead to better diagnosis and treatment options tailored to individual genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are diagnosed with Autism Spectrum Disorder and are minimally verbal.
Not a fit: Patients who are not diagnosed with Autism Spectrum Disorder or who are verbally proficient may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for minimally verbal children with autism.
How similar studies have performed: Previous research has shown promise in identifying genetic factors associated with ASD, suggesting that this approach could yield valuable insights.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GESCHWIND, DANIEL H — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: GESCHWIND, DANIEL H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.